Label: POLYETHYLENE GLYCOL 3350 powder, for solution

  • NDC Code(s): 58602-805-01, 58602-805-02, 58602-805-03, 58602-805-04, view more
    58602-805-25, 58602-805-27
  • Packager: Aurohealth LLC
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated April 26, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • Drug Facts

    Active ingredient (in each dose)

    Polyethylene Glycol 3350, USP 17 grams (cup filled to the indicated 17 grams line)

  • Purpose

    Osmotic Laxative

  • Use

    • relieves occasional constipation (irregularity)
    • generally produces a bowel movement in 1 to 3 days
  • Warnings

    Allergy alert: Do not use if you are allergic to polyethylene glycol

  • DO NOT USE

    Do not use if you have kidney disease, except under the advice and supervision of a doctor

  • Ask a doctor before use if you have

    • nausea, vomiting or abdominal pain
    • a sudden change in bowel habits that lasts over 2 weeks
    • irritable bowel syndrome
  • ASK DOCTOR/PHARMACIST

    Ask a doctor or pharmacist before use if you are taking a prescription drug

  • WHEN USING

    When using this product you may have loose, watery, more frequent stools

  • Stop use and ask a doctor if

    • you have rectal bleeding or your nausea, bloating, cramping or abdominal pain gets worse. These may be signs of a serious condition.
    • you get diarrhea
    • you need to use a laxative for longer than 1 week
  • PREGNANCY OR BREAST FEEDING

    If pregnant or breast-feeding, ask a health professional before use.

  • Keep out of reach of children.

    In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

  • Directions

    • do not take more than directed unless advised by your doctor
    • this product is supplied with a dosing cup marked to contain 17 grams of powder when filled to the indicated line
    • adults and children 17 years of age and older:
      • use once a day
      • fill to the indicated 17 grams line on cup which is marked to indicate the correct dose 17 grams
      • stir and dissolve in any 4 to 8 ounces of beverage (cold, hot or room temperature) then drink
      • do not combine with starch-based thickeners used for difficulty swallowing
      • ensure that the powder is fully dissolved before drinking
      • do not drink if there are any clumps
      • do not use no more than 7 days
    • children 16 years of age or under: ask a doctor
  • Other information

    • store at 20° to 25°C (68° to 77°F)
    • tamper-evident: do not use if foil seal under cap, printed with "SEALED for YOUR PROTECTION" is missing, open or broken
  • Inactive ingredients

    none

    Questions or comments?

    call 1-855-274-4122
    Distributed by:
    AUROHEALTH LLC
    279 Princeton-Hightstown Road
    East Windsor, NJ 08520

    Made in India

    Code: TS/DRUGS/19/1993

  • PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 119 g Bottle Label

    AUROHEALTH

    NDC 58602-805-01

    Compare to active ingredient
    of MiraLax®*

    Polyethylene Glycol 3350
    Powder for Oral Solution

    Osmotic Laxative

    • Relieves Occasional Constipation/Irregularity
    • Softens Stool

    UNFLAVORED POWDER - GRIT FREE

    7 ONCE-DAILY DOSES            NET WT 4.1 OZ (119 g)
     
    PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 119 g Bottle Label
     

  • PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 17 g Sachet Label

    AUROHEALTH

    NDC 58602-805-26

    Compare to active ingredient
    of MiraLax®*

    Polyethylene Glycol 3350
    Powder for Oral Solution

    Osmotic Laxative

    • Relieves Occasional Constipation/Irregularity
    • Softens Stool
    • Sugar Free
    • Dissolves in any Beverage

    UNFLAVORED POWDER - GRIT FREE

    1 DOSE

    NET WT 0.5 oz (17 g)

    PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 17 g Sachet Carton Label

  • PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 17 g Sachet Carton Label

    AUROHEALTH

    NDC 58602-805-27

    Compare to active ingredient
    of MiraLax®*

    Polyethylene Glycol 3350
    Powder for Oral Solution

    Osmotic Laxative

    Polyethylene Glycol 3350 powder for
    oral solution increases frequency of
    bowel movements and softness the stool.

    • Relieves Occasional Constipation/Irregularity
    • Softens Stool
    • Sugar Free
    • Dissolves in Any Beverage

    14 ONCE-DAILY DOSES

    UNFLAVORED POWDER - GRIT FREE

    14 PRE-MEASURED, SINGLE DOSES

    14 Packets
    NET WT 0.5 oz
    (17 g) Each

    PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 17 g Sachet Label

  • INGREDIENTS AND APPEARANCE
    POLYETHYLENE GLYCOL 3350 
    polyethylene glycol 3350 powder, for solution
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:58602-805
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    POLYETHYLENE GLYCOL 3350 (UNII: G2M7P15E5P) (POLYETHYLENE GLYCOL 3350 - UNII:G2M7P15E5P) POLYETHYLENE GLYCOL 335017 g  in 17 g
    Product Characteristics
    ColorWHITEScore    
    ShapeSize
    FlavorImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:58602-805-01119 g in 1 BOTTLE, PLASTIC; Type 1: Convenience Kit of Co-Package04/09/2018
    2NDC:58602-805-02238 g in 1 BOTTLE, PLASTIC; Type 1: Convenience Kit of Co-Package04/09/2018
    3NDC:58602-805-03510 g in 1 BOTTLE, PLASTIC; Type 1: Convenience Kit of Co-Package04/09/2018
    4NDC:58602-805-04850 g in 1 BOTTLE, PLASTIC; Type 1: Convenience Kit of Co-Package04/09/2018
    5NDC:58602-805-25765 g in 1 BOTTLE, PLASTIC; Type 1: Convenience Kit of Co-Package04/23/2024
    6NDC:58602-805-2714 in 1 CARTON04/23/2024
    617 g in 1 PACKET; Type 1: Convenience Kit of Co-Package
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA20901704/09/2018
    Labeler - Aurohealth LLC (078728447)
    Establishment
    NameAddressID/FEIBusiness Operations
    Aurobindo Pharma Limited918917642ANALYSIS(58602-805) , MANUFACTURE(58602-805)
    Establishment
    NameAddressID/FEIBusiness Operations
    APL HEALTHCARE LIMITED650844777ANALYSIS(58602-805) , MANUFACTURE(58602-805)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!